Antiplatelet therapy: controversial aspects.

Abstract excerpt

Although the efficacy of antiplatelet therapy is supported by numerous studies areas of uncertainty and doubt persist both in secondary and in primary prevention. In both settings it can be surmised that, with few exceptions, the relative risk reduction obtained, for instance, with aspirin, is rather uniform across the different clinical conditions and measures "efficacy" of the drug: while the absolute risk...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiovascular Diseases
• Share to Evidence-Based Medicine
• Share to Hemorrhage